fda proposes to lower the bar on alzheimer's d, page-6

I have been waiting for someone to connect FDA urgency with Big Pharma needs. Prana has scientists and MDs who are world leaders and Big Pharma have a major problem in brain degeneratrive development drugs- they fail consistently and have few in advanced stages of development.
What I want to say to PBT executives is- You have the scientific basis of a possible compound that alone, or probably in combination, shows considerable promise for AD,HD and perhaps Parkinsons.
Prana are at a pivot point in proof of process, and Big Pharma are increasingly desperate to credibly enter the field.
Don't let them in! Price rather than results is their motivation. Back yourselves until they really get desperate.